Evidence map›Paper›PMID 34073643›Full record

ArticleMicroorganisms2021

In Vitro Reduced Susceptibility to Pentavalent Antimonials of a

Aurora Diotallevi, Gloria Buffi, Giovanni Corbelli, Marcello Ceccarelli, Margherita Ortalli, Stefania Varani, Mauro Magnani, Luca Galluzzi

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Aurora DiotalleviDepartment of Biomolecular Sciences, University of Urbino "Carlo Bo", 61029 Urbino, Italy.ORCID 0000-0001-5456-1821
Gloria BuffiDepartment of Biomolecular Sciences, University of Urbino "Carlo Bo", 61029 Urbino, Italy.
Giovanni CorbelliUnit of Infectious Diseases, Marche Nord Hospital, 61122 Pesaro, Italy.
Marcello CeccarelliDepartment of Biomolecular Sciences, University of Urbino "Carlo Bo", 61029 Urbino, Italy.
Margherita OrtalliUnit of Microbiology, IRCCS Polyclinic S.Orsola-Malpighi, 40138 Bologna, Italy.
Stefania VaraniUnit of Microbiology, IRCCS Polyclinic S.Orsola-Malpighi, 40138 Bologna, Italy.ORCID 0000-0003-0862-4937
Mauro MagnaniDepartment of Biomolecular Sciences, University of Urbino "Carlo Bo", 61029 Urbino, Italy.ORCID 0000-0001-6456-6626
Luca GalluzziDepartment of Biomolecular Sciences, University of Urbino "Carlo Bo", 61029 Urbino, Italy.ORCID 0000-0002-1747-526X
University of Urbino · ITIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITOspedali Riuniti Marche Nord · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous leishmaniasis (CL) caused by

Indexed as

antimonialscutaneous leishmaniasisLeishmania infantumresistance

Identifiers

PMID34073643
PMCPMC8229719
OpenAlexW3164052038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.